Pletikošić, S., Plavsic, I., Hauser, G. & Tkalčić, M. (2015). Fecal Calprotectin and serum chromogranin A as potential biomarkers of irritable bowel syndrome symptom severity. Medical Hypotheses, 85. (3), 339-342. doi: 10.1016/j.mehy.2015.06.008
Pletikošić, Sanda, et al. "Fecal Calprotectin and serum chromogranin A as potential biomarkers of irritable bowel syndrome symptom severity." Medical Hypotheses, vol. 85, no. 3, 2015, pp. 339-342. https://doi.org/10.1016/j.mehy.2015.06.008
Pletikošić, Sanda, Ivana Plavsic, Goran Hauser and Mladenka Tkalčić. "Fecal Calprotectin and serum chromogranin A as potential biomarkers of irritable bowel syndrome symptom severity." Medical Hypotheses 85, no. 3 (2015): 339-342. https://doi.org/10.1016/j.mehy.2015.06.008
Pletikošić, S., et al. (2015) 'Fecal Calprotectin and serum chromogranin A as potential biomarkers of irritable bowel syndrome symptom severity', Medical Hypotheses, 85(3), pp. 339-342. doi: 10.1016/j.mehy.2015.06.008
Pletikošić S, Plavsic I, Hauser G, Tkalčić M. Fecal Calprotectin and serum chromogranin A as potential biomarkers of irritable bowel syndrome symptom severity. Medical Hypotheses [Internet]. 2015 September [cited 2024 December 13];85(3):339-342. doi: 10.1016/j.mehy.2015.06.008
S. Pletikošić, I. Plavsic, G. Hauser and M. Tkalčić, "Fecal Calprotectin and serum chromogranin A as potential biomarkers of irritable bowel syndrome symptom severity", Medical Hypotheses, vol. 85, no. 3, pp. 339-342, September 2015. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:150848. [Accessed: 13 December 2024]